Meghna Jani (Megna Jani)

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 36

Top Topics

Rheumatoid Arthritis

Disease Activity

Transcranial Magnetic Stimulation

Top Venues

Annals of the rheumatic diseases

Rheumatology advances in practice

This page only lists publications with an associated author ORCID identifier.

Publications

Meghna Jani, Ghada Alfattni, Maksim Belousov, Lynn Laidlaw, Yuanyuan Zhang, Michael Cheng, Karim Webb, Robyn Hamilton, Andrew S Kanter, William Gregory Dixon, Goran Nenadic
Development and evaluation of a text analytics algorithm for automated application of national COVID-19 shielding criteria in rheumatology patients. Annals of the rheumatic diseases (2024)
Carlos Raúl Ramírez Medina, Mengyu Feng, Yun-Ting Huang, David A Jenkins, Meghna Jani
Machine learning identifies risk factors associated with long-term opioid use in fibromyalgia patients newly initiated on an opioid. RMD open 10 (2) (2024)
Yun-Ting Huang, William G Dixon, Terence W O'Neill, Meghna Jani
Postoperative opioids administered to inpatients with major or orthopaedic surgery: A retrospective cohort study using data from hospital electronic prescribing systems. PloS one 19 (6) (2024)
Philippa D K Curry, Andrew P Morris, Meghna Jani, Gabriela Arredondo Hector Chinoy, Richard B Warren, James Bluett, null null
Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response. Rheumatology advances in practice 8 (1) (2024)
Carlos Raúl Ramírez Medina, Mengyu Feng, Yun-Ting Huang, David A Jenkins, Meghna Jani
Machine learning identifies risk factors associated with long-term opioid use in fibromyalgia patients newly initiated on an opioid. RMD open 10 (2) (2024)
Max Lyon, Sizheng Steven Zhao, Meghna Jani, Gabriela Arredondo Hector Chinoy, Richard B Warren, James Bluett, null null
The influence of deprivation in the outcomes of psoriatic arthritis within the UK-utilizing Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) data. Rheumatology advances in practice 8 (2) (2024)
Yun-Ting Huang, William G Dixon, Terence W O'Neill, Meghna Jani
Postoperative opioids administered to inpatients with major or orthopaedic surgery: A retrospective cohort study using data from hospital electronic prescribing systems. PloS one 19 (6) (2024)
Meghna Jani, Ghada Alfattni, Maksim Belousov, Lynn Laidlaw, Yuanyuan Zhang, Michael Cheng, Karim Webb, Robyn Hamilton, Andrew S Kanter, William Gregory Dixon, Goran Nenadic
Development and evaluation of a text analytics algorithm for automated application of national COVID-19 shielding criteria in rheumatology patients. Annals of the rheumatic diseases 83 (8) (2024)
Max Lyon, Sizheng Steven Zhao, Meghna Jani, Gabriela Arredondo Hector Chinoy, Richard B Warren, James Bluett, null null
The influence of deprivation in the outcomes of psoriatic arthritis within the UK-utilizing Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) data. Rheumatology advances in practice 8 (2) (2024)
Thomas Khoo, Meghna Jani, Hector Chinoy
Is there a role for novel supplements in the management of fatigue in rheumatic diseases? RMD open 10 (3) (2024)
Max Lyon, Sizheng Steven Zhao, Meghna Jani, Gabriela Arredondo Hector Chinoy, Richard B Warren, James Bluett, null null
The influence of deprivation in the outcomes of psoriatic arthritis within the UK-utilizing Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) data. Rheumatology advances in practice 8 (2) (2024)
Carlos Raúl Ramírez Medina, Mengyu Feng, Yun-Ting Huang, David A Jenkins, Meghna Jani
Machine learning identifies risk factors associated with long-term opioid use in fibromyalgia patients newly initiated on an opioid. RMD open 10 (2) (2024)
Thomas Khoo, Meghna Jani, Hector Chinoy
Is there a role for novel supplements in the management of fatigue in rheumatic diseases? RMD open 10 (3) (2024)
Thomas Khoo, Meghna Jani, Hector Chinoy
Is there a role for novel supplements in the management of fatigue in rheumatic diseases? RMD open 10 (3) (2024)
Meghna Jani, Ghada Alfattni, Maksim Belousov, Lynn Laidlaw, Yuanyuan Zhang, Michael Cheng, Karim Webb, Robyn Hamilton, Andrew S Kanter, William Gregory Dixon, Goran Nenadic
Development and evaluation of a text analytics algorithm for automated application of national COVID-19 shielding criteria in rheumatology patients. Annals of the rheumatic diseases 83 (8) (2024)
Philippa D K Curry, Andrew P Morris, Meghna Jani, Gabriela Arredondo Hector Chinoy, Richard B Warren, James Bluett, null null
Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response. Rheumatology advances in practice 8 (1) (2024)
Meghna Jani, Ghada Alfattni, Maksim Belousov, Lynn Laidlaw, Yuanyuan Zhang, Michael Cheng, Karim Webb, Robyn Hamilton, Andrew S Kanter, William Gregory Dixon, Goran Nenadic
Development and evaluation of a text analytics algorithm for automated application of national COVID-19 shielding criteria in rheumatology patients. Annals of the rheumatic diseases 83 (8) (2024)
Philippa D K Curry, Gabriela Arredondo Hector Chinoy, Meghna Jani, Darren Plant, Kimmie L Hyrich, Ann W Morgan, Anthony G Wilson, John Dudley Isaacs, Andrew P Morris, Richard B Warren, James Bluett
The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort. The Journal of rheumatology (2023)
Meghna Jani, Belay Birlie Yimer, David A Selby, Mark Lunt, Goran Nenadic, William Gregory Dixon
"Take up to eight tablets per day": Incorporating free-text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology. Pharmacoepidemiology and drug safety (2023)
Meghna Jani, Belay Birlie Yimer, David Selby, Mark Lunt, Goran Nenadic, William G Dixon
"Take up to eight tablets per day": Incorporating free-text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology. Pharmacoepidemiology and drug safety (2023)
Yun-Ting Huang, David A Jenkins, Niels Peek, William Gregory Dixon, Meghna Jani
High frequency of long-term opioid use among patients with rheumatic and musculoskeletal diseases initiating opioids for the first time. Annals of the rheumatic diseases (2023)
Johanna Elin Gehin, Guro Løvik Goll, Marthe Kirkesaether Brun, Meghna Jani, Nils Bolstad, Silje Watterdal Syversen
Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (6) (2022)
Annette de Thurah, Philipp Bosch, Andrea Marques, Yvette Meißner, Chetan B Mukhtyar, Johannes Knitza, Aurélie Najm, Nina Østerås, Tim Pelle, Line Raunsbæk Knudsen, Hana Šmucrová, Francis Berenbaum, Meghna Jani, Rinie Geenen, Krusche Martin, Polina Pchelnikova, Savia de Souza, Sara Badreh, Dieter Wiek, Silvia Piantoni, James M Gwinnutt, Christina Duftner, Helena M Canhão, Luca Quartuccio, Nikolay Stoilov, Yeliz Prior, Johannes W J Bijlsma, Alen Zabotti, Tanja Alexandra Stamm, Christian Dejaco
2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. Annals of the rheumatic diseases 81 (8) (2022)
Charlotte Lm Krieckaert, Astrid van Tubergen, Johanna Elin Gehin, Borja Hernández-Breijo, Guillaume Le Mélédo, Alejandro Balsa, Peter Böhm, Sasa Cucnik, Ori Elkayam, Guro L Goll, Femke Hooijberg, Meghna Jani, Patrick Dw Kiely, Neil McCarthy, Denis Mulleman, Victoria Navarro-Compán, Katherine Payne, Martin E Perry, Chamaida Plasencia-Rodriguez, Simon R Stones, Silje Watterdal Syversen, Annick de Vries, Katherine M Ward, Gertjan Wolbink, John Dudley Isaacs
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases. Annals of the rheumatic diseases (2022)
Charlotte Lm Krieckaert, Borja Hernández-Breijo, Johanna Elin Gehin, Guillaume le Mélédo, Alejandro Balsa, Meghna Jani, Denis Mulleman, Victoria Navarro-Compan, Gertjan Wolbink, John Isaac, Astrid van Tubergen
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider. RMD open 8 (2) (2022)
Hassan Rana, Goran Nenadic, William Gregory Dixon, Meghna Jani
Perceptions of opioid use and impact on quality of life in patients with musculoskeletal conditions within online health community forums. Rheumatology advances in practice 5 (3) (2021)
Irina A Tikhonova, Huiqin Yang, Segun Bello, Andrew Salmon, Sophie Robinson, Mohsen Rezaei Hemami, Sophie Dodman, Andriy Kharechko, Richard C Haigh, Meghna Jani, Timothy James McDonald, Martin Hoyle
Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation. Health technology assessment (Winchester, England) 25 (8) (2021)
Meghna Jani, Nadyne Girard, David Westfall Bates, David L Buckeridge, Therese Sheppard, Yu Chuan Jack Li, Usman Iqbal, Shelly Vik, Colin Weaver, Judy Seidel, William Gregory Dixon, Robyn Tamblyn
Opioid prescribing among new users for non-cancer pain in the USA, Canada, UK, and Taiwan: A population-based cohort study. PLoS medicine 18 (11) (2021)
Arianna Dagliati, Darren Plant, Nisha Nair, Meghna Jani, Beatrice Amico, Niels Peek, Ann W Morgan, John Isaacs, Anthony G Wilson, Kimme L Hyrich, Nophar Geifman, Anne Barton, null null
Latent Class Trajectory Modeling of 2-Component Disease Activity Score in 28 Joints Identifies Multiple Rheumatoid Arthritis Phenotypes of Response to Biologic Disease-Modifying Antirheumatic Drugs. Arthritis & rheumatology (Hoboken, N.J.) 72 (10) (2020)
Meghna Jani, Belay Birlie Yimer, Therese Sheppard, Mark Lunt, William G Dixon
Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study. PLoS medicine 17 (10) (2020)
Sean P Gavan, Meghna Jani, James Bluett, Katherine Payne, Richard B Warren
Therapeutic monitoring of TNF inhibitors for rheumatoid arthritis: evidence required following NICE's recommendations. Rheumatology advances in practice 4 (2) (2020)
Meghna Jani, William G Dixon, Lianne Kersley-Fleet, Ian N Bruce, Hector Chinoy, Anne Barton, Mark Lunt, Kath Watson, null null, null null, Deborah P M Symmons, Kimme L Hyrich
Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA. RMD open 3 (1) (2017)
Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, Jackie Nam, Josef S Smolen, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Chris D Buckley, Frank Buttgereit, Vivian Bykerk, Mario Humberto Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk-Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan Gomez-Reino, Laure Gossec, Jacques-Eric Gottenberg, Johanna M W Hazes, Tom Huizinga, Meghna Jani, Dmitry Karateev, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain McInnes, Eduardo Mysler, Peter Nash, Karel Pavelka, Gyula Poór, Christophe Richez, Piet van Riel, Andrea Rubbert-Roth, Kenneth Saag, José António Pereira Da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the rheumatic diseases 76 (6) (2017)
Elena Nikiphorou, Paul Studenic, Alessia Alunno, Mary Canavan, Meghna Jani, Francis Berenbaum
'Twitterland': a brave new world? Annals of the rheumatic diseases 77 (8) (2017)
Elena Nikiphorou, Paul Studenic, Christian Gytz Ammitzbøll, Mary Canavan, Meghna Jani, Caroline Ospelt, Francis Berenbaum, null null
Social media use among young rheumatologists and basic scientists: results of an international survey by the Emerging EULAR Network (EMEUNET). Annals of the rheumatic diseases 76 (4) (2016)
Meghna Jani, John D Isaacs, Ann W Morgan, Anthony G Wilson, Darren Plant, Kimmie L Hyrich, Hector Chinoy, Richard B Warren, null null
High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort. Annals of the rheumatic diseases 76 (1) (2016)